Clinical TrialID 5657
Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis
NCT01703078
Actinic Keratosis
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 5657
- Evidence Id
- 5657
- Core Evidence Id
- 5657
- Source Clinical Trial Id
- 5643
- Herb2 Clinical Trial Id
- HBCT005643
- Nct Id
- NCT01703078
- Title
- Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis
- Status
- Completed
- Phase
- Phase 1
- Study Result
- No
- Study Condition
- Actinic Keratosis
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: TREATMENT
- Intervention
- DRUG: Ingenol once daily for two consecutive days
- Intervention Allocation
- Randomized
- Intervention Model
- Single_Group
- Intervention Mask
- Single
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Adult, Older_Adult
- Enrollment
- 41
- Outcome Measure
- Safety of a new ingenol derivative compared to ingenol mebutate gel applied topically once daily for two consecutive days to four separate treatment areas containing actinic keratosis on the forearm, Safety data to be collected via CRF entries of AEs/SAEs and photographs., 8 weeks
- Sponsor Collaborator
- LEO Pharma
- Funded By
- INDUSTRY
- Location
- Dermatology Department, Woolloongabba, Queensland, 4102, Australia
- Other Id
- LP0084-68
- Start Date
- 2012-11
- Primary Completion Date
- 2013-03
- Completion Date
- 2013-04
- First Posted
- 2012-10-10
- Results First Posted
- Last Update Posted
- 2013-04-04
- Study Document
- Study Url
- https://clinicaltrials.gov/study/NCT01703078
- Title Cn
- Title En
- Safety and Tolerability of Different Concentrations of an Ingenol Derivative Field Therapy in the Treatment of Actinic Keratosis
- Bilingual Status
- semi_complete